BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Acosta MBD, Lorenzo A, Dominguez-Muñoz JE. Adalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years. World J Gastroenterol 2009; 15(30): 3814-3816 [PMID: 19673025 DOI: 10.3748/wjg.15.3814]
URL: https://www.wjgnet.com/1007-9327/full/v15/i30/3814.htm
Number Citing Articles
1
Walter Reinisch. Crohn's Disease and Ulcerative Colitis2017; : 435 doi: 10.1007/978-3-319-33703-6_43
2
Z. Arora, B. Shen. Biological therapy for ulcerative colitisGastroenterology Report 2015; 3(2): 103 doi: 10.1093/gastro/gou070
3
Brijen Shah, Lloyd Mayer. Current status of monoclonal antibody therapy for the treatment of inflammatory bowel diseaseExpert Review of Clinical Immunology 2010; 6(4): 607 doi: 10.1586/eci.10.45
4
Marisa Iborra, Javier Pérez-Gisbert, Marta Maia Bosca-Watts, Alicia López-García, Valle García-Sánchez, Antonio López-Sanromán, Esther Hinojosa, Lucía Márquez, Santiago García-López, María Chaparro, Montserrat Aceituno, Margalida Calafat, Jordi Guardiola, Blanca Belloc, Yolanda Ber, Luis Bujanda, Belén Beltrán, Cristina Rodríguez-Gutiérrez, Jesús Barrio, José Luis Cabriada, Montserrat Rivero, Raquel Camargo, Manuel van Domselaar, Albert Villoria, Hugo Salata Schuterman, David Hervás, Pilar Nos. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patientsJournal of Gastroenterology 2017; 52(7): 788 doi: 10.1007/s00535-016-1274-1
5
Gionata Fiorino, Laurent Peyrin-Biroulet, Alessandro Repici, Alberto Malesci, Silvio Danese. Adalimumab in ulcerative colitis: hypes and hopesExpert Opinion on Biological Therapy 2011; 11(1): 109 doi: 10.1517/14712598.2011.541435
6
Bruno Rafael Ramos de Mattos, Maellin Pereira Gracindo Garcia, Julia Bier Nogueira, Lisiery Negrini Paiatto, Cassia Galdino Albuquerque, Caique Lopes Souza, Luís Gustavo Romani Fernandes, Wirla Maria da Silva Cunha Tamashiro, Patricia Ucelli Simioni, Even Fossum. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsMediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/493012
7
Yago González-Lama, María Isabel Vera, Marta Calvo, Lluís Abreu. Marcadores de evolución de la enfermedad inflamatoria intestinal tratada con inmunomoduladores o agentes biológicosGastroenterología y Hepatología 2010; 33(6): 449 doi: 10.1016/j.gastrohep.2009.11.005
8
Natalia López-Palacios, Juan L. Mendoza, Carlos Taxonera, Raquel Lana, José Miguel Esteban López-Jamar, Manuel Díaz-Rubio. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapyEuropean Journal of Internal Medicine 2011; 22(6): 621 doi: 10.1016/j.ejim.2011.06.017
9
William J. Sandborn, Gert van Assche, Walter Reinisch, Jean–Frederic Colombel, Geert D’Haens, Douglas C. Wolf, Martina Kron, Mary Beth Tighe, Andreas Lazar, Roopal B. Thakkar. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology 2012; 142(2): 257 doi: 10.1053/j.gastro.2011.10.032
10
Ming-Hsi Wang, Jean-Paul Achkar. Medical Therapy of Ulcerative Colitis2014; : 185 doi: 10.1007/978-1-4939-1677-1_16
11
Manuel Barreiro-de Acosta, Orlando García-Bosch, Jordi Gordillo, Miriam Mañosa, Luis Menchén, Raquel Souto, Ignacio Marin-Jimenez. Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximabEuropean Journal of Gastroenterology & Hepatology 2012; 24(7): 756 doi: 10.1097/MEG.0b013e3283525a7b
12
Stefano Nobile, Paolo Gionchetti, Fernando Rizzello, Carlo Calabrese, Massimo Campieri. Mucosal healing in pediatric Crohn’s disease after anti-TNF therapyEuropean Journal of Gastroenterology & Hepatology 2014; 26(4): 458 doi: 10.1097/MEG.0000000000000045
13
Mark A. Samaan, Preet Bagi, Niels Vande Casteele, Geert R. D’Haens, Barrett G. Levesque. An Update on Anti-TNF Agents in Ulcerative ColitisGastroenterology Clinics of North America 2014; 43(3): 479 doi: 10.1016/j.gtc.2014.05.006
14
Edmée C.M. Sikkens, Djuna L. Cahen, Casper van Eijck, Ernst J. Kuipers, Marco J. Bruno. The Daily Practice of Pancreatic Enzyme Replacement Therapy After Pancreatic Surgery: a Northern European SurveyJournal of Gastrointestinal Surgery 2012; 16(8): 1487 doi: 10.1007/s11605-012-1927-1
15
Walter Reinisch. Crohn's Disease and Ulcerative Colitis2012; : 495 doi: 10.1007/978-1-4614-0998-4_41
16
Silvio Danese. Adalimumab in ulcerative colitis: Ready for prime timeDigestive and Liver Disease 2013; 45(1): 8 doi: 10.1016/j.dld.2012.05.021
17
Ya-qian Jia, Zi-wen Yuan, Xiao-song Zhang, Jia-qi Dong, Xue-nan Liu, Xiao-ting Peng, Wan-ling Yao, Peng Ji, Yan-ming Wei, Yong-li Hua. Total alkaloids of Sophora alopecuroides L. ameliorated murine colitis by regulating bile acid metabolism and gut microbiotaJournal of Ethnopharmacology 2020; 255: 112775 doi: 10.1016/j.jep.2020.112775
18
Christopher Ma, Vivian Huang, Darryl K. Fedorak, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Richard N. Fedorak. Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of ResponseJournal of Clinical Gastroenterology 2015; 49(8): 675 doi: 10.1097/MCG.0000000000000265
19
Zong Mei Zhang, Wei Li, Xue Liang Jiang. Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled TrialsGut and Liver 2016; 10(2): 262 doi: 10.5009/gnl15042
20
C. Taxonera, J. Estellés, I. Fernández-Blanco, O. Merino, I. Marín-Jiménez, M. Barreiro-de Acosta, C. Saro, V. García-Sánchez, E. Gento, G. Bastida, J. P. Gisbert, I. Vera, P. Martinez-Montiel, S. Garcia-Morán, M. C. Sánchez, J. L. Mendoza. Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabAlimentary Pharmacology & Therapeutics 2011; 33(3): 340 doi: 10.1111/j.1365-2036.2010.04531.x